Form 4: Ginkgo Bioworks CFO Mark Dmytruk Reports Stock Transactions

Mark Dmytruk, CFO of Ginkgo Bioworks Holdings, reports multiple transactions involving Class A and Class B Common Stock, including acquisitions, disposals, and conversions, according to a Form 4 filing.

Summary

• On August 1, 2024, Mark Dmytruk, CFO of Ginkgo Bioworks Holdings, engaged in multiple transactions involving the company's stock.
• These transactions included the acquisition of Class A Common Stock through the vesting of restricted stock units (RSUs).
• Dmytruk also converted 1,636 shares of Class B Common Stock into Class A Common Stock.
• On August 2, 2024, Dmytruk disposed of 63,567 shares of Class A Common Stock at a price of $0.287 per share.
• These sales were to cover tax withholding obligations related to the vesting of restricted stock and/or restricted stock units.
• Following these transactions, Dmytruk directly owns 1,088,186 shares of Class A Common Stock and 622,141 shares of Class B Common Stock.
• Dmytruk also holds 450,639 RSUs that vest in monthly installments beginning April 1, 2023, 561,875 RSUs that vest in monthly installments beginning April 1, 2024 and 985,417 RSUs that vest in monthly installments beginning April 1, 2024.

Sentiment

Score: 5

Explanation: The document is a routine filing of stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.

Stakeholder Impact

• Shareholders are informed about the CFO's stock transactions, providing transparency into insider activity.

Key Dates